… Breast cancer appears to be the cancer type in which CTC … in breast cancer patients, the
issues faced by the molecular characterization of CTC and the biological findings about cancer …

… a sentinel-node biopsy for breast cancer before 2006 and had breast cancer with favorable
primary-tumor characteristics and isolated tumor cells or micrometastases in the regional …

… From a total of 189 breast tumor samples consisting of 177 primary tumors and 12 … 21 human
breast tumor cell lines that included 18 cell lines derived from primary tumors and 3 derived …

… In a prospective, multicenter study, we tested 177 patients with measurable metastatic breast
cancer for levels of circulating tumor cells both before the patients were to start a new line …

… We have focused on breast cancer as most clinical studies on … Breast cancer specific markers
have been used (ie, HER2, … all breast cancer tumors or on every cell of a particular tumor, …

… defined numbers of cells (average, 50 and 1,000, respectively), cell stability based on …
tumor cells, inter-instrument variability, and positivity of samples from metastatic breast cancer …

… tumor cells (DTC) in the bone marrow of breast cancer patients 7. CTC detection and enumeration
in breast cancer … survival and overall survival in operable breast cancer before 8,–,12 …

… breast cancer dormancy have tumor cells in their blood. Cancer cells have not previously
been described in patients with remote primary cancer who are at very low risk of recurrence. …

… value of circulating tumor cells (CTC) detected in breast cancer patients is currently … breast
cancer patients, as well as progression-free survival (PFS) and OS in metastatic breast cancer …

… Five or more circulating tumor cells (CTCs) per 7.5 mL of blood predicts for poorer
progression-free survival (PFS) in patients with metastatic breast cancer (MBC). We conducted a …